Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer
Clinical trial NCT04211896 · UNKNOWN
Trial details
- NCT number
- NCT04211896
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-07-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.